Search research articles
Contact Us
Filters
Showing results (221-230 of 241) with videos related to
Page
of 25
Sort By:
Nature Neuroscience
|
May 18, 2000
Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype
R M McKernan, T W Rosahl, D S Reynolds, et al.
Journal of Medicinal Chemistry
|
October 27, 2015
A Novel Pyrazolopyridine with in Vivo Activity in Plasmodium berghei- and Plasmodium falciparum-Infected Mouse Models from Structure-Activity Relationship Studies around the Core of Recently Identified Antimalarial Imidazopyridazines
Claire Le Manach, Tanya Paquet, Christel Brunschwig, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 18, 2005
Evidence for a significant role of alpha 3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines
Rebecca Dias, Wayne F A Sheppard, Rosa L Fradley, et al.
Journal of Psychopharmacology (Oxford, England)
|
February 17, 2010
Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist
J R Atack, D J Hallett, S Tye, et al.
Journal of Medicinal Chemistry
|
February 17, 2006
Discovery of imidazo[1,2-b][1,2,4]triazines as GABA(A) alpha2/3 subtype selective agonists for the treatment of anxiety
Michael G N Russell, Robert W Carling, Leslie J Street, et al.
Journal of Medicinal Chemistry
|
October 26, 2020
Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and <i>In Vivo</i> Efficacy in the <i>Plasmodium falciparum</i> NSG Mouse Model
André Horatscheck, Ana Andrijevic, Aloysius T Nchinda, et al.
Journal of Medicinal Chemistry
|
January 28, 2021
Correction to "Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and <i>In Vivo</i> Efficacy in the <i>Plasmodium falciparum</i> NSG Mouse Model"
André Horatscheck, Ana Andrijevic, Aloysius T Nchinda, et al.
The Journal of Antimicrobial Chemotherapy
|
February 9, 2018
Potent Plasmodium falciparum gametocytocidal compounds identified by exploring the kinase inhibitor chemical space for dual active antimalarials
Mariëtte E van der Watt, Janette Reader, Alisje Churchyard, et al.
Journal of Medicinal Chemistry
|
October 18, 2016
Identification of a Potential Antimalarial Drug Candidate from a Series of 2-Aminopyrazines by Optimization of Aqueous Solubility and Potency across the Parasite Life Cycle
Claire Le Manach, Aloysius T Nchinda, Tanya Paquet, et al.
ACS Infectious Diseases
|
March 10, 2018
2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization
Dinakaran Murugesan, Peter C Ray, Tracy Bayliss, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 241) with videos related to
Sort By:
Page
of 25
Nature Neuroscience
|
May 18, 2000
Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype
R M McKernan, T W Rosahl, D S Reynolds, et al.
Journal of Medicinal Chemistry
|
October 27, 2015
A Novel Pyrazolopyridine with in Vivo Activity in Plasmodium berghei- and Plasmodium falciparum-Infected Mouse Models from Structure-Activity Relationship Studies around the Core of Recently Identified Antimalarial Imidazopyridazines
Claire Le Manach, Tanya Paquet, Christel Brunschwig, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
November 18, 2005
Evidence for a significant role of alpha 3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines
Rebecca Dias, Wayne F A Sheppard, Rosa L Fradley, et al.
Journal of Psychopharmacology (Oxford, England)
|
February 17, 2010
Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist
J R Atack, D J Hallett, S Tye, et al.
Journal of Medicinal Chemistry
|
February 17, 2006
Discovery of imidazo[1,2-b][1,2,4]triazines as GABA(A) alpha2/3 subtype selective agonists for the treatment of anxiety
Michael G N Russell, Robert W Carling, Leslie J Street, et al.
Journal of Medicinal Chemistry
|
October 26, 2020
Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and <i>In Vivo</i> Efficacy in the <i>Plasmodium falciparum</i> NSG Mouse Model
André Horatscheck, Ana Andrijevic, Aloysius T Nchinda, et al.
Journal of Medicinal Chemistry
|
January 28, 2021
Correction to "Identification of 2,4-Disubstituted Imidazopyridines as Hemozoin Formation Inhibitors with Fast-Killing Kinetics and <i>In Vivo</i> Efficacy in the <i>Plasmodium falciparum</i> NSG Mouse Model"
André Horatscheck, Ana Andrijevic, Aloysius T Nchinda, et al.
The Journal of Antimicrobial Chemotherapy
|
February 9, 2018
Potent Plasmodium falciparum gametocytocidal compounds identified by exploring the kinase inhibitor chemical space for dual active antimalarials
Mariëtte E van der Watt, Janette Reader, Alisje Churchyard, et al.
Journal of Medicinal Chemistry
|
October 18, 2016
Identification of a Potential Antimalarial Drug Candidate from a Series of 2-Aminopyrazines by Optimization of Aqueous Solubility and Potency across the Parasite Life Cycle
Claire Le Manach, Aloysius T Nchinda, Tanya Paquet, et al.
ACS Infectious Diseases
|
March 10, 2018
2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion Characterization
Dinakaran Murugesan, Peter C Ray, Tracy Bayliss, et al.
Page
of 25